NICE Guidelines: management of colorectal cancer metastases

  title={NICE Guidelines: management of colorectal cancer metastases},
  author={Michael J. Baum and Lesley Fallowfield and Vernon T Farewell and Fergus Macbeth and Tom Treasure},
  journal={British Journal of Surgery},
Editor The NICE recommendations to ‘consider’ surgical resection for colorectal cancer (CRC) metastases should worry those who value evidence-informing surgical practice1. There are no randomized controlled trials (RCT) of liver metastasectomy primarily due to liver surgeons’ opposition2. The effectiveness of peritoneal cytoreductive surgery (CRS) could not be deduced from the RCTs cited, because it was in both arms1. The evidence given supporting lung metastasectomy is poor: one retrospective… 
The PulMiCC Trial Provides Control Data for Colorectal Lung Metastases Amenable to Local Treatments
The authors frequently refer to the ‘‘favourable survival’’ from surgical or RFA intervention but, in the absence of control data, survival cannot be attributed to the effect of the interventions, rather than to case selection alone.
Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer
The most current status on the importance of pathological features in prognostication and recommendations for adjuvant therapy in Australia and New Zealand is provided.
Pathological Features and Prognostication in Colorectal Cancer
A comprehensive review of the pathological features and biomarkers that are important in the prognostication and treatment of CRC based on the current evidence in the literature is provided.
Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy
It is found that repurposing CPZ is a novel treatment strategy for CRC patients by inducing G2/M cell cycle arrest and apoptosis and suppressing lung metastasis of CT26 cells and prolonged mice survival.
Medical statistics, Austin Bradford Hill, and a celebration of 40 years of Statistics in Medicine
It is celebrated 40 years of this remarkable journal by commenting on the Alfred Watson Memorial Lecture delivered by Austin Bradford Hill, in 1962, after first reflecting on some issues raised in the first editorial of the journal and providing some details on Hill’s career.


Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
This phase II trial is the first randomized study demonstrating that aggressive local treatment can prolong OS in patients with unresectable colorectal liver metastases, and a statistically significant difference in OS in favor of the combined modality arm.
Factors Influencing Oncological Outcomes in Patients Who Develop Pulmonary Metastases After Curative Resection of Colorectal Cancer
Prelaparotomy serum CEA level may be an especially reliable predictor of both overall survival and recurrence-free survival after pulmonary metastasectomy in patients who undergo curative resection for colorectal cancer.
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed
The clinical effectiveness of lung metastases from colorectal cancer being resected in selected patients in the belief that this confers a significant survival advantage is tested in a randomized, controlled noninferiority trial.
Colorectal cancer: summary of NICE guidance
Recent recommendations from the update of the National Institute for Health and Care Excellence (NICE) guideline for the diagnosis and management of colorectal cancer are summarized.
Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance
This study highlights the need to understand more fully the role ofitoneal malignancy in women’s health and the importance of regular check-up and follow-up care after pregnancy.